Amiodarone and breast feeding [1]

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 88, Issue 3, 2003, Pages

  Hall, C M ^a   McCormick, K P B ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; MILK FAT;

ASCITES; BREAST FEEDING; BREAST MILK; DRUG HALF LIFE; DRUG MILK LEVEL; HUMAN; LETTER; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; TACHYCARDIA; THYROID DISEASE;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; BREAST FEEDING; FETAL DISEASES; HUMANS; INFANT, NEWBORN; MILK, HUMAN; MONITORING, PHYSIOLOGIC; TACHYCARDIA;

EID: 0037880388     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Plomp TA, Vulsma T, de Vijlder JJM. Use of amiodarone during pregnancy. European Journal of Obstetrics and Gynecology and Reproductive Biology 1992;42:201-7.
2. Pitcher D, Leather HM, Storey GCA, et al. Amiodarone in pregnancy. Lancet 1983;i:597-8.
3. Sanofi-Synthelabs. Summary of product characteristics, Cordarone X. Sanofi-Synthelabo, UK.
4. McKenna WJ, Harris L, Rowland E, et al. Amiodarone therapy during pregnancy. Am J Cardiol 1983;51:1231-3.